Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats

The sodium-glucose-cotransporter-2 (SGLT2) inhibitor dapagliflozin (DAPA) induces glucosuria and osmotic diuresis via inhibition of renal glucose reabsorption. Since increased diuresis retards the progression of polycystic kidney disease (PKD), we investigated the effect of DAPA in the PCK rat model...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Sarika, Rodriguez, Daniel, Riwanto, Meliana, Edenhofer, Ilka, Segerer, Stephan, Mitchell, Katharyn, Wüthrich, Rudolf P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416041/
https://www.ncbi.nlm.nih.gov/pubmed/25927597
http://dx.doi.org/10.1371/journal.pone.0125603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416041/
https://www.ncbi.nlm.nih.gov/pubmed/25927597
http://dx.doi.org/10.1371/journal.pone.0125603

Ejemplares similares